Cst7tm1Ike
Targeted Allele Detail
|
|
| Symbol: |
Cst7tm1Ike |
| Name: |
cystatin F (leukocystatin); targeted mutation 1, Kazuhiro Ikenaka |
| MGI ID: |
MGI:5910746 |
| Synonyms: |
CysFKD, CysFSTOP-tetO |
| Gene: |
Cst7 Location: Chr2:150412335-150420864 bp, + strand Genetic Position: Chr2, 74.67 cM, cytoband G1-G3
|
| Alliance: |
Cst7tm1Ike page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:242069
|
| Parent Cell Line: |
RENKA (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Conditional ready, Null/knockout) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: A Neo STOP-tetO cassette was inserted just upstream of the translation initiation site. The cassette contains the following elements: a loxP site, an FRT site, a neomycin resistance gene cassette, a transcription and translation STOP cassette, an FRT site, a tetO cassette (the tetracycline operon site and a CMV minimal promoter) and a loxP site. In the absence of tetracycline transactivator (tTA) activity this allele is a null allele. The gene can be activated by expressing tTA (by crossing with a tTA transgenic mouse) in the absence of tetracycline family antibiotics.
(J:242069)
|
|
|
|
|
| Original: |
J:242069 Shimizu T, et al., The balance between cathepsin C and cystatin F controls remyelination in the brain of Plp1-overexpressing mouse, a chronic demyelinating disease model. Glia. 2017 Jun;65(6):917-930 |
| All: |
1 reference(s) |
|
Analysis Tools
